Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Frontiers in Medicine|August 20, 2021
Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting PeptideDanny Alon, Yossi Paitan, Eyal Robinson, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCRCyrille J Cohen, Zhili Zheng, Regina Bray, et al.Cancer Research|April 19, 2007
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bondCyrille J Cohen, Yong F Li, Mona El-Gamil, et al.Frontiers in Immunology|April 4, 2025
Hexokinase2-engineered T cells display increased anti-tumor functionRaphaëlle Toledano Zur, Shiran Didi Zurinam, Maria Radman, et al.Oncoimmunology|June 9, 2021
A novel role for an old target: CD45 for breast cancer immunotherapyAnnat Raiter, Oran Zlotnik, Julia Lipovetsky, et al.Journal for Immunotherapy of Cancer|July 4, 2024
Genetically engineering glycolysis in T cells increases their antitumor functionRaphaëlle Toledano Zur, Orna Atar, Tilda Barliya, et al.Oncotarget|April 21, 2017
A novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activityLital Gasri-Plotnitsky, Aviv Ovadia, Katerina Shamalov, et al.Cell Reports|April 5, 2018
Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus ErythematosusShalom Hillel Roth, Miri Danan-Gotthold, Meirav Ben-Izhak, et al.Frontiers in Immunology|November 1, 2017
Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric ReceptorVasyl Eisenberg, Katerina Shamalov, Shimrit Meir, et al.ACS Nano|June 4, 2015
Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT ImagingRinat Meir, Katerina Shamalov, Oshra Betzer, et al.Pageof 6